跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 281 条关于
“MZ-1866”
全部
281
临床试验
111
药物
159
机构
1
资讯
10
24天前
Mahzi Therapeutics' MZ-1866 Gene Therapy Receives FDA Rare Pediatric Disease Designation for Pitt Hopkins Syndrome
6个月前
Mahzi Therapeutics Doses First Patient in Groundbreaking Gene Therapy Trial for Pitt Hopkins Syndrome
去年
Wave Life Sciences' RNA Editing Data Sparks Rally in RNA Therapy Stocks
去年
LAVA Therapeutics Doses First Patient in Phase 1 Trial of LAVA-1266 for Hematological Cancers
2年前
Rhenium-186 Obisbemeda Shows Promise in Recurrent Glioblastoma Trial
2年前
MediciNova's Ibudilast (MN-166) Shows Promise in COMBAT-ALS Trial: Interim Analysis to be Presented at International Symposium
去年
MediciNova's Ibudilast (MN-166) Shows Promise in ALS Treatment: Phase 2/3 Trial Update
去年
First Patient Enrolled in NIH-Funded Expanded Access Program for MN-166 in Advanced ALS
去年
Plus Therapeutics Receives FDA Clearance for Phase 1 Trial of Rhenium-186 Obisbemeda in Recurrent Glioblastoma
3个月前
MediciNova's MN-166 (Ibudilast) Advances Toward Pivotal ALS Data as Phase 2b/3 COMBAT-ALS Trial Completes Enrollment